2.28
9.62%
0.20
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BCLI?
Forum
Prognose
Aktiensplit
Finanzdaten der Brainstorm Cell Therapeutics Inc-Aktie (BCLI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Research and Development |
43.40%
0.961
|
1.698 | 3.33 | 2.794 | 2.924 |
Operating Income/Loss |
48.50%
-2.474
|
-4.804 | -6.035 | -5.449 | -5.151 |
Income/Loss From Continuing Operations Before Tax |
39.03%
-3.401
|
-5.578 | -1.226 | -5.329 | -5.059 |
Income/Loss From Continuing Operations After Tax |
39.03%
-3.401
|
-5.578 | -1.226 | -5.329 | -5.059 |
Net Income/Loss
|
39.03%
-3.401
|
-5.578 | -1.226 | -5.329 | -5.059 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,195%
64.74
|
2.8204 | 44.25 | 39.70 | 36.74 |
Diluted Average Shares |
2,195%
64.74
|
2.8204 | 44.25 | 39.70 | 36.74 |
Basic Earnings Per Share |
54.55%
-0.05
|
-0.11 | -0.03 | -0.13 | -0.14 |
Diluted Earnings Per Share |
54.55%
-0.05
|
-0.11 | -0.03 | -0.13 | -0.14 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):